Dissection of two routes to naïve pluripotency using different kinase inhibitors
Naïve pluripotency can be stabilized through different pharmacological approaches. Here, the authors profile temporal changes of protein phosphorylation, proteome and metabolome as mESCs transition to the naïve state in response to two pharmacological treatments, revealing general and treatment-spec...
Guardado en:
Autores principales: | Ana Martinez-Val, Cian J. Lynch, Isabel Calvo, Pilar Ximénez-Embún, Fernando Garcia, Eduardo Zarzuela, Manuel Serrano, Javier Munoz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dc7983421e549f8afada656ff5c28a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation
por: Hemalvi Patani, et al.
Publicado: (2020) -
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs
por: Yongli Shan, et al.
Publicado: (2017) -
Direct comparison of distinct naive pluripotent states in human embryonic stem cells
por: S. Warrier, et al.
Publicado: (2017) -
Parallel derivation of isogenic human primed and naive induced pluripotent stem cells
por: Stéphanie Kilens, et al.
Publicado: (2018) -
Evobrutinib, a covalent Bruton’s tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants
por: Holger Scheible, et al.
Publicado: (2021)